This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Only 13.4% immunocompromised adult US veterans younger than 50 years received the recombinant zoster vaccine by mid-2023, which reflected a lag in the adoption of revised national recommendations.
Medscape Medical News